Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 58

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 58
---
 there may not be sufficient liquidity in its securities
when such shareholders wish to sell their public shares.

You are not being asked to vote on the Business Combination at the Meeting. The vote by the Company shareholders on the Business Combination will occur at the separate Business Combination Meeting of the Company shareholders and the solicitation of proxies from the Company shareholders in connection with such separate Business Combination Meeting, and the related right of the Company shareholders to redeem in connection with the Business Combination (which is a separate right to redeem in addition to the right to redeem in connection with the M&A Amendment Proposals), is the subject of a separate proxy statement/prospectus. If you want to ensure your Public Shares are redeemed in the event the M&A Amendments are approved at the Meeting, you should elect to “redeem” your Public Shares in connection with the Meeting.

Reasons for the Proposed Extension Amendment

The M&A currently provides
that the Company has until December 15, 2025 to complete an initial business combination. The Company does not believe it will consummate
an initial business combination prior to December 15, 2025. The purpose of the Extension Amendment is to allow the Company more time
to complete the Business Combination.

We intend to hold another
shareholder meeting prior to the Extended Date in order to seek shareholder approval of the Business Combination. If the M&A Amendments
are approved and implemented, the Board will have the flexibility to liquidate the Trust Account to redeem all public shares on a specified
date following the approval and implementation of the M&A Amendments at any time before or after December 15, 2025, and prior
to the end of the Extension Period.

<div align='center'>37</div>

If the M&A Amendments are Approved

If the M&A Amendments
are approved and implemented, the Company will file the M&A in the form of Annex A hereto to extend the time it has to complete
a Business Combination until the Extended Date. The Company will then continue to attempt to consummate a Business Combination until the
Extended Date, or until such earlier date as determined by the Board in its sole discretion. The Company will remain a reporting company
under the Securities and Exchange Act of 1934 (the “Exchange Act”) and its Class A Ordinary
Shares and Public Warrants will remain publicly traded during this time.

You are not being asked to vote on the Business Combination at the Meeting. The vote by the Company shareholders on the Business Combination will occur at the separate Business Combination Meeting of the Company